Kazia Therapeutics (KZIA) director details existing ADS option grants
Rhea-AI Filing Summary
Kazia Therapeutics director Ebru Davidson has filed an initial ownership report outlining existing option-based exposure to the company’s American Depositary Shares (ADSs). The filing shows two ADS option positions, each giving the right to buy ADSs at fixed exercise prices before their respective expiration dates.
One ADS option covers 75,000 underlying ADSs at an exercise price of $8.0000 per ADS, expiring on July 3, 2027. Another ADS option covers 2,000 underlying ADSs at an exercise price of $0.3348 per ADS, expiring on April 30, 2027. Footnotes explain that one grant vests in equal quarterly installments over three years beginning April 30, 2024, while another vested 100% on July 3, 2025, in each case conditioned on continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Davidson Ebru
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Share Option (Right to Buy) | -- | -- | -- |
| holding | American Depositary Share Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
American Depositary Share Option (Right to Buy) — 2,000 shares (Direct)
Footnotes (1)
- The American Depositary Shares ("ADSs") subject to the option ("ADS option") vest in equal quarterly installments over three years beginning on April 30, 2024, subject to the Reporting Person's continuous service relationship with the Issuer through each applicable vesting date. The ADS option was granted on April 30, 2024. Each ADS option is convertible into ADSs upon exercise. Each ADS may be represented by 500 ordinary shares of the Issuer, no par per share (the "Ordinary Shares"), at any time, upon the holder's election to surrender the ADSs and withdraw the respective number of Ordinary Shares. The ADSs have no expiration date. The ADSs subject to the ADS option vested as to 100% on July 3, 2025. The ADS option was granted on July 3, 2025.
Key Figures
ADS options underlying shares: 75,000 ADSs
ADS option exercise price: $8.0000 per ADS
Second ADS options underlying shares: 2,000 ADSs
+4 more
7 metrics
ADS options underlying shares
75,000 ADSs
Underlying shares for one option grant; exercise price $8.0000
ADS option exercise price
$8.0000 per ADS
Exercise price for 75,000 underlying ADSs; expires July 3, 2027
Second ADS options underlying shares
2,000 ADSs
Underlying shares for second option grant; exercise price $0.3348
Second ADS option exercise price
$0.3348 per ADS
Exercise price for 2,000 underlying ADSs; expires April 30, 2027
Quarterly vesting schedule start
April 30, 2024
Start of three-year equal quarterly vesting for one ADS option
Full vesting date for one grant
July 3, 2025
ADSs under one ADS option vested 100% on this date
ADS to ordinary share ratio
1 ADS = 500 ordinary shares
Representation of Kazia ordinary shares per ADS; ADSs have no expiration
Key Terms
American Depositary Shares, vesting, exercise price, expiration date, +1 more
5 terms
vesting financial
"ADSs subject to the option vest in equal quarterly installments over three years"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
exercise price financial
"conversion_or_exercise_price: "8.0000" and "0.3348" per ADS"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2027-07-03" and "2027-04-30" for the ADS options"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
continuous service relationship financial
"subject to the Reporting Person's continuous service relationship with the Issuer"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Kazia Therapeutics (KZIA) director Ebru Davidson report on this Form 3?
The Form 3 reports Ebru Davidson’s existing holdings of options over American Depositary Shares of Kazia Therapeutics. It lists two ADS option positions, their exercise prices, expiration dates, and the number of underlying ADSs covered by each option grant.
What are the exercise prices of Ebru Davidson’s Kazia Therapeutics ADS options?
The filing shows exercise prices of $8.0000 per American Depositary Share for one option grant and $0.3348 per ADS for the second grant. These exercise prices define the cost per ADS if Davidson chooses to exercise the corresponding options.
When do Ebru Davidson’s Kazia Therapeutics ADS options expire?
One ADS option position expires on July 3, 2027, and the other expires on April 30, 2027. After those expiration dates, the respective options can no longer be exercised to acquire American Depositary Shares of Kazia Therapeutics.
How do Davidson’s Kazia Therapeutics ADS options vest over time?
One ADS option grant vests in equal quarterly installments over three years beginning April 30, 2024, subject to continuous service. Another grant vested as to 100% on July 3, 2025, meaning all ADSs under that option became exercisable on that vesting date.